Grifols, S.A.
Grifols, S.A. (NASDAQ: GRFS) is trading at $7.30, about ₹701 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, down 1.55% today. Indian residents can buy Grifols from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$7.23
Today's high
$7.42
52 week low
$6.96
52 week high
$10.23
GRFS opened at $7.40, closed previously at $7.41, and has traded between $6.96 and $10.23 over the past 52 weeks.
About
Grifols, S.A., a company founded in 1940 and headquartered in Barcelona, Spain, specializes in the development, manufacture, and distribution of therapeutic products, with a primary focus on those derived from human plasma. Its operations are organized into several divisions. The Bioscience division is dedicated to researching, producing, and marketing plasma-derived medicines, such as immunoglobulins, alpha-1 antitrypsin, albumin, and clotting factors, along with other innovative treatments for chronic, rare, prevalent, and life-threatening conditions. The Hospital division provides non-biological pharmaceuticals, medical supplies, clinical nutrition solutions, intravenous therapies, and medical devices. The Diagnostic division develops, manufactures, and commercializes diagnostic products that span the entire healthcare continuum, from prevention and screening to diagnosis, prognosis, and monitoring of diseases and treatments, catering to professional healthcare providers. The Bio Supplies division offers essential biological materials for life-science research, clinical trials, and the manufacturing of pharmaceutical and diagnostic products. These diverse offerings enable healthcare professionals to diagnose and treat patients suffering from conditions like hemophilia, immune deficiencies, and infectious diseases. Grifols serves a wide array of clients, including public and private healthcare organizations, wholesalers, distributors, group purchasing organizations, blood banks, hospitals, and national health systems. The company also maintains a technology collaboration agreement with Mondragon.
Key statistics
Avg. volume
631.74K
Market cap
$6.17B
P/E Ratio
14.16
Price-to-sales ratio
0.87
Enterprise value
€13.33B
Free cash flow yield
13.87%
Debt-to-equity ratio
1.54
Return on equity
7.33%
ROIC
5.33%
Beta
1.19
Dividend yield
0.87%
Last dividend
$0.28
Financial overview
Revenue
€7.23B
Earnings per share
€0.57
Free cash flow
€751.14M
Net profit margin
6.09%
Gross margin
37.23%
EBITDA
€1.62B
Revenue growth
0.20%
Similar securities
This is not an investment recommendation
How to buy Grifols from India
Indian residents can buy Grifols shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Grifols and place an order
Find Grifols by name or by its ticker, GRFS, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Grifols trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Grifols position in USD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Grifols from India
Trading and taxes when buying Grifols from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Grifols’ current yield is 0.87%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Grifols stock?
Yes. Grifols (GRFS) has been listed on NASDAQ since 2011, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Grifols share cost in rupees?
One Grifols share is $7.30 — about ₹701 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Grifols price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Grifols from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Grifols?
Yes. One Grifols share is $7.30, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Grifols.
How are gains on Grifols shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Grifols price. Paasa issues a capital-gains statement for your return.
Does Grifols pay a dividend, and how is it taxed in India?
Yes. Grifols pays a dividend and the current yield is 0.87%; the last declared dividend was $0.28 per share, about ₹27.05. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Grifols from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is Grifols a United States company, and does that change how it is taxed?
Grifols trades on NASDAQ in US dollars, but the company is domiciled in Spain. Grifols trades as an American Depositary Receipt rather than an ordinary share. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare Grifols shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Grifols holding, its cost and its closing value.
How do I sell Grifols and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.